China's independent research and development of gene sequencer launched | is expected to break the monopoly of foreign countries

According to the Voice of Economic World Financial Report, BGI recently officially launched two new gene sequencing systems for scientific research market. At present, the approval documents required for clinical application are still being submitted. This high-performance sequencer localization, it will greatly reduce the cost of gene sequencing, for the people, medical treatment will benefit.

According to the CNR news on November 2, the so-called genetic sequencing, refers to a new type of genetic testing technology that can analyze the whole sequence of the gene from blood or saliva, predict the occurrence of multiple disease Of the possibility for the common people, gene sequencing technology can lock individual disease genes, prevention and treatment in advance.Therefore, genetic sequencing equipment is the focus of market chase.

Prior to this, the genetic sequencer by the United States, a global monopoly company, but with our country completely independent research and development of the third generation of gene sequencer appearance, this one dominance is expected to be broken.In applications, by a number of research The results of the joint research show that the third generation of single-gene sequencer in China test results 100% accurate, can be successfully applied to non-invasive prenatal testing.

The introduction of the new gene sequencer GenBank PR director Fei said that if this high-performance sequencer localization, the future can effectively reduce the cost of gene sequencing.

Xiang Fei: 'The two newly released products have a very big improvement over the existing ones, they are faster, more information can be read at a time, and more people can be detected at a time. Machine changes, the cost of further decline in the future For ordinary people, genetic testing are acceptable in terms of price.

For ordinary consumers, through the genetic test is revealed in the end hidden in the life of the code? Yinyu CEO Yoo Yee had previously said that genetic testing for clinical significance.

Yin Ye: 'If we can understand life science correctly and understand genes, then we can stay away from birth defects and stay away Tumor , Away from cardiovascular and cerebrovascular diseases, the infection can not be confused treatment, these are all things we hope.

Genome's head of PR communications Xiang Fei said that the body's genes can help us to better find the root cause of the disease.

Xiang Fei: 'The latest genetic test of this pathogenic microorganism can actually make high-throughput genetic testing and analysis through the patient's blood or other tissue fluid. It can accurately find out exactly which virus invades the human body and causes the human body Fever, and then find the corresponding drugs for this virus symptomatic treatment.

In the entire gene sequencing market, as the price drop, the market is constantly breaking.Fei Fei revealed that the future of domestic genetic sequencer will bring down the price to 100 yuan.Although at present, gene sequencing also faces the bottleneck of data accumulation, But no matter what, with the advent of a homemade genetic sequencer developed independently in China, its contribution to medical treatment will benefit more people.